Role of EZH2 Inhibitor Combined with Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells
Background and objective Lung cancer is one of the common malignant tumors that impair human health. With the development of epigenetics, the researchers found that enhancer of Zeste homolog 2 (EZH2) is highly expressed in lung cancer tissue and its expression is closely related to the prognosis. EZ...
Salvato in:
| Autori principali: | , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Chinês |
| Pubblicazione: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-05-01
|
| Serie: | Chinese Journal of Lung Cancer |
| Soggetti: | |
| Accesso online: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.01 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|